Metabolomics and network pharmacology exploration of the effects of bile acids on carotid atherosclerosis and potential underlying mechanisms.

Background: Bile acids (BAs), products of gut microbiota metabolism, have long been implicated in atherosclerotic disease pathogenesis. Characterizing the serum bile acid profile and exploring its potential role in carotid atherosclerosis (CAS) development are crucial tasks. Methods: In this study, we recruited 73 patients with CAS as the disease group and 77 healthy individuals as the control group. We systematically measured the serum concentrations of 15 bile acids using ultrahigh-performance liquid chromatography-mass spectrometry (UPLC-MS/MS). Multivariate logistic regression and least absolute shrinkage and selection operator (LASSO) regression were applied to analyze the impact of bile acids on the disease and select the key BAs. The possible molecular mechanism was elucidated by network pharmacology. Results: (1) The BA profile of patients with CAS significantly differed. (2) Multifactorial logistic regression analysis identified elevated levels of GCDCA (OR: 1.01, P < 0.001), DCA (OR: 1.01, P = 0.005), and TDCA (OR: 1.05, P = 0.002) as independent risk factors for CAS development. Conversely, GCA (OR: 0.99, P = 0.020), LCA (OR: 0.83, P = 0.002), and GUDCA (OR: 0.99, P = 0.003) were associated with protective effects against the disease. GCA, DCA, LCA, and TDCA were identified as the four key BAs. (3) TNF, FXR, GPBAR1, ESR1 and ACE were predicted to be targets of BAs against AS. These four BAs potentially impact AS progression by triggering signaling pathways, including cAMP, PPAR, and PI3K-AKT pathways, via their targets. Conclusion: This study offers valuable insights into potential therapeutic strategies for atherosclerosis that target bile acids.

Synergistic Dual-Salt Electrolyte for Safe and High-Voltage LiNi0.8Co0.1Mn0.1O2//Graphite Pouch Cells.

Concerns about thermal safety and unresolved high-voltage stability have impeded the commercialization of high-energy lithium-ion batteries bearing LiNi0.8Co0.1Mn0.1O2 (NCM811) cathodes. Enhancing the cathode structure and optimizing the electrolyte formula have demonstrated significant potential in improving the high-voltage properties of batteries while simultaneously minimizing thermal hazards. The current study reports the development of a high-voltage lithium-ion battery that is both safe and reliable, using single-crystal NCM811 and a dual-salt electrolyte (DSE). After 200 cycles at high voltage (up to 4.5 V), the capacity retention of the battery with DSE was 98.80%, while that for the battery with a traditional electrolyte was merely 86.14%. Additionally, in comparison to the traditional electrolyte, the DSE could raise the tipping temperature of a battery's thermal runaway (TR) by 31.1 °C and lower the maximum failure temperature by 76.1 °C. Moreover, the DSE could effectively reduce the battery's TR heat release rate (by 23.08%) as well as eliminate concerns relating to fire hazards (no fire during TR). Based on material characterization, the LiDFOB and LiBF4 salts were found to facilitate the in situ formation of an F- and B-rich cathode-electrolyte interphase, which aids in inhibiting oxygen and interfacial side reactions, thereby reducing the intensity of redox reactions within the battery. Therefore, the findings indicate that DSE is promising as a safe and high-voltage lithium-ion battery material.